CLINICAL RESEARCH: MYOCARDIAL INFARCTION
Long-Term Outcome and its Predictors Among Patients With ST-Segment Elevation Myocardial Infarction Complicated by ShockInsights From the GUSTO-I Trial
Mandeep Singh, MD*,
Jennifer White, MS ,
David Hasdai, MD ,
Patricia K. Hodgson, BA ,
Peter B. Berger, MD ,
Eric J. Topol, MD||,
Robert M. Califf, MD and
David R. Holmes, Jr, MD*,*
* Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota
Duke Clinical Research Institute, Durham, North Carolina
Rabin Medical Center, Petah Tikva, Israel
Geisinger Clinic, Danville, Pennsylvania
|| Scripps Research Institute, La Jolla, California.
Manuscript received January 26, 2007;
revised manuscript received April 16, 2007,
accepted April 30, 2007.
* Reprint requests and correspondence: Dr. David R. Holmes, Jr., Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, 200 1st Street SW, Rochester, Minnesota 55905. (Email: holmes.david{at}mayo.edu).
Objectives: This study sought to assess long-term outcome and determine its predictors among 30-day survivors of cardiogenic shock.
Background: Patients with cardiogenic shock have high in-hospital and 30-day mortality, but there are little data about those who survive beyond 30 days.
Methods: We analyzed baseline, in-hospital, and survival data from patients in the U.S. with ST-segment elevation myocardial infarction (STEMI) and cardiogenic shock enrolled in the GUSTO (Global Utilization of Streptokinase and Tissue-Type Plasminogen Activator for Occluded Coronary Arteries)-I trial and compared them with patients in the same trial who did not have shock.
Results: Of 22,883 patients enrolled in the U.S., shock occurred in 1,891 (8.3%); 953 (50.4%) survived 30 days and 527 (27.8%) survived 11 years. Of 20,992 U.S. patients without shock, 20,360 (96.9%) survived 30 days and 14,131 (67.3%) survived 11 years. After the first year, 2% to 4% of patients died each year regardless of whether they had cardiogenic shock. Using Cox proportional hazards models, we were able to predict long-term mortality in all U.S. GUSTO-I 30-day survivors from their baseline demographics and in-hospital complications. The strongest predictors were diabetes mellitus, cardiogenic shock, hypertension, previous myocardial infarction, current smoking, anterior infarct, higher Killip class, higher heart rate, and older age; patients >75 years were at highest risk. Percutaneous revascularization during the index hospitalization was associated with a reduced risk of death.
Conclusions: Among patients with cardiogenic shock who survive 30 days after STEMI, annual mortality rates of 2% to 4% approximate those of patients without shock.
|
Abbreviations and Acronyms
| | MI = myocardial infarction | | NDI = National Death Index | | STEMI = ST-segment elevation myocardial infarction |
|
Related Article
-
The Calm After the Storm: Long-Term Survival After Cardiogenic Shock
- Judith S. Hochman and Renato Apolito
J. Am. Coll. Cardiol. 2007 50: 1759-1760.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
C. A. den Uil, S. D.A. Valk, J. M. Cheng, A. P. Kappetein, A. J.J.C. Bogers, R. T. van Domburg, and M. L. Simoons
Prognosis of patients undergoing cardiac surgery and treated with intra-aortic balloon pump counterpulsation prior to surgery: a long-term follow-up study
Interactive CardioVascular and Thoracic Surgery,
August 1, 2009;
9(2):
227 - 231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. S. Lim, O. Farouque, N. Andrianopoulos, B. P. Yan, C. C.S. Lim, A. L. Brennan, C. M. Reid, M. Freeman, K. Charter, A. Black, et al.
Survival of Elderly Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction Complicated by Cardiogenic Shock
J. Am. Coll. Cardiol. Intv.,
February 1, 2009;
2(2):
146 - 152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Hochman and A. H. Skolnick
Contemporary Management of Cardiogenic Shock: Age Is Opportunity
J. Am. Coll. Cardiol. Intv.,
February 1, 2009;
2(2):
153 - 155.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. V. Jeger, D. Radovanovic, P. R. Hunziker, M. E. Pfisterer, J.-C. Stauffer, P. Erne, P. Urban, and for the AMIS Plus Registry Investigators
Ten-Year Trends in the Incidence and Treatment of Cardiogenic Shock
Ann Intern Med,
November 4, 2008;
149(9):
618 - 626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Roik and G. Opolski
Long-Term Outcome Among Patients With ST-Segment Elevation Myocardial Infarction Complicated by Shock
J. Am. Coll. Cardiol.,
July 22, 2008;
52(4):
315 - 315.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Holmes Jr
Reply
J. Am. Coll. Cardiol.,
July 22, 2008;
52(4):
316 - 316.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Callans
Can Home AEDs Improve Survival?
N. Engl. J. Med.,
April 24, 2008;
358(17):
1853 - 1855.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. H. Bardy, K. L. Lee, D. B. Mark, J. E. Poole, W. D. Toff, A. M. Tonkin, W. Smith, P. Dorian, D. L. Packer, R. D. White, et al.
Home Use of Automated External Defibrillators for Sudden Cardiac Arrest
N. Engl. J. Med.,
April 24, 2008;
358(17):
1793 - 1804.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. R. Reynolds and J. S. Hochman
Cardiogenic Shock: Current Concepts and Improving Outcomes
Circulation,
February 5, 2008;
117(5):
686 - 697.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, P. Clopton, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, J. D. Knoke, W. Y.W. Lew, J. A.C. Lima, et al.
Highlights of the year in JACC 2007.
J. Am. Coll. Cardiol.,
January 29, 2008;
51(4):
490 - 512.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Hochman and R. Apolito
The Calm After the Storm: Long-Term Survival After Cardiogenic Shock
J. Am. Coll. Cardiol.,
October 30, 2007;
50(18):
1759 - 1760.
[Full Text]
[PDF]
|
 |
|
|